AstraZeneca Annual Report and Board of Directors 08 Form 20-F Information 2004 at 31 December 2004 Board of Directors at 31 December 2004 Percy Barnevik Sir Tom McKillop Jonathan Symonds Non-Executive Chairman Executive Director Chief Executive Executive Director Chief Financial Officer Hkan Mogren Sir Peter Bonfield Jane Henney Non-Executive Deputy Chairman Senior Non-Executive Director Non-Executive Director Louis Schweitzer Marcus Wallenberg Michele Hooper Non-Executive Director Non-Executive Director Non-Executive Director John Buchanan Dame Bridget Ogilvie Joe Jimenez Non-Executive Director Non-Executive Director Non-Executive Director Erna Mller Non-Executive Director Retired from the Board on 31 December 2004 Appointed Non-Executive Chairman with effect from 1 January 2005 AstraZeneca Annual Report and Board of Directors Form 20-F Information 2004 at 31 December 2004 09 Jonathan Symonds 45 Percy Barnevik 63 Sir Tom McKillop 61 Non-Executive Chairman Executive Director and Chief Executive Executive Director and Chief Financial Chairman of the Nomination Committee Appointed as a Director 1 January 1996.
Officer Appointed as a Director 6 April 1999.
Retired Non-Executive Director of BP p. l. c. and Appointed as a Director 1 October 1997. from the Board on 31 December 2004. until 31 December 2004 Lloyds TSB Also has overall responsibility for Information Honorary Chairman of Sandvik AB.
Vice-President of the European Services.
Non-Executive Director of Diageo Executive Director of General Motors Federation of Pharmaceutical Industries plc.
Member of the UK Accounting Corporation.
Member of the Academies of and Associations.
Pro-Chancellor of the Standards Board.
Chairman of The Hundred Engineering Sciences in Sweden and University of Leicester.
Chairman of the Group of Finance Directors in the UK.
Finland and Honorary Member of the Royal British Pharma Group and the Northwest Academy of Engineering, UK.
Jane Henney 57 the International Advisory Council of the Non-Executive Director Federation of Korean Industries and the Sir Peter Bonfield CBE, FREng 60 Member of the Audit Committee, the Investment Council advising the South Senior Non-Executive Director Nomination Committee and the Science African Government.
Member of the Chairman of the Remuneration Committee Business Council of American CEOs.
Committee and Member of the Appointed as a Director 24 September Member of the Advisory Board of the Centre Nomination Committee 2001.
Senior Vice-President & Provost for for European Reform, UK.
Health Affairs, University of Cincinnati Fellow of the Royal Academy of Medical Center.
Commissioner of Food Hkan Mogren 60 Engineering.
Non-Executive Director and Drugs 1998-2001 and Deputy Non-Executive Deputy Chairman of Telefonaktiebolaget LM Ericsson, Commissioner for Operations 1992-1994, Member of the Nomination Committee Mentor Graphics Corporation and Taiwan US Food and Drug Administration.
Deputy Appointed as a Director 6 April 1999.
Semiconductor Manufacturing Company, Director, US National Cancer Institute Formerly CEO and a Director of Astra AB Ltd.
Vice-President of The British Quality 1980-1995.
Non-Executive Director of appointed 18 May 1988.
Member of the Citigroup AmerisourceBergen Corporation and Affibody AB and the Sweden-America International Advisory Board.
Member of the Board Foundation.
the Sony Corporation Advisory Board.
of Trustees of the Commonwealth Fund Member of the Board of Directors of Non-Executive Director, Corporate Board and the China Medical Board.
Investor AB, Rmy Cointreau SA, Groupe of the Department for Constitutional Affairs.
Danone and Norsk Hydro ASA.
Director of Michele Hooper 53 the Marianne and Marcus Wallenberg Marcus Wallenberg 48 Non-Executive Director Foundation.
Non-Executive Director Member of the Audit Committee Member of the Audit Committee Appointed as a Director 1 July 2003.
Louis Schweitzer 62 Appointed as a Director 6 April 1999.
President and Chief Executive Officer of Non-Executive Director Formerly a Director of Astra AB appointed Stadtlander Drug Company 1998-1999.
President and Chief Executive Corporate Vice-President and President, Appointed Non-Executive Chairman and Officer of Investor AB.
Non-Executive International Businesses of Caremark Chairman of the Nomination Committee Vice-Chairman of Saab AB, Skandinaviska International Inc. 1992-1998.
Chairman Enskilda Banken AB and Telefonaktiebolaget Executive Director of PPG Industries, Inc. and Chief Executive Officer of Renault SA LM Ericsson.
Non-Executive Director of Target Corporation and Davita Inc. since May 1992.
President of the Scania AB, Stora Enso Oyj and the Knut Management Board of Renault-Nissan BV and Alice Wallenberg Foundation.
Chief Financial Officer Non-Executive Director and Executive Vice-President 1988-1992 John Buchanan 61 Member of the Remuneration and President and Chief Operating Officer Non-Executive Director Committee and the Nomination 1990-1992, Renault SA.
Non-Executive Chairman of the Audit Committee and Committee Director of BNP-Paribas, Electricit fide Member of the Remuneration Committee Appointed as a Director 1 July 2003.
France, Philips Electronics NV, Veolia Appointed as a Director 25 April 2002.
Executive Vice-President of H J Heinz Environnement and Volvo AB.
Executive Director and Group Chief Financial Company and President and Chief Officer of BP p. l. c. 1996-2002.
Member of Executive Officer of Heinz Europe since Dame Bridget Ogilvie 66 the UK Accounting Standards Board 1997- 2002.
Corporate Vice-President then Non-Executive Director 2001.
Senior Independent Non-Executive Senior Vice-President and President of Member of the Audit Committee Director of BHP Billiton Plc and NonHeinz North America 1998-2002.
Nonand the Science Committee Executive Director of Vodafone Group Plc.
Executive Director of Blue Nile, Inc.
Also has responsibility for overseeing Erna Mller 64 Other officers of the Company at corporate responsibility.
Chairman of the Non-Executive Director 31 December 2004 included members Medicines for Malaria Venture and the Member of the Remuneration of the Senior Executive Team, as set out Association of Medical Research Charities.
Committee and the Science Committee on page 54, and: Trustee of Cancer Research UK.
Chairman Appointed as a Director 6 April 1999. of the Trustees of the AstraZeneca Science Formerly a Director of Astra AB appointed Graeme Musker Teaching Trust.
Executive Director of the Group Secretary and Solicitor Knut and Alice Wallenberg Foundation.
Appointed as Company Secretary Professor of Clinical Immunology and 6 June 1993.
Member of the Nobel Assembly and of the Nobel Committee, Karolinska Institutet.
Member of the Royal Swedish Academy of Engineering Sciences and the Royal Swedish Academy of Science.
